Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients

This case report series describes 3 cases of cisatracurium besylate associated phlebitis after an infusion period of 14–20 hours. No similar cases have been reported in the literature. Association of phlebitis with another neuromuscular blocking agent, atracurium, has been described in the literatur...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMJ Case Rep
Main Authors: Meeder, Annelijn M, van der Steen, Marijke S, Rozendaal, Annemieke, van Zanten, Arthur R H
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5073701/
https://ncbi.nlm.nih.gov/pubmed/27698008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-216448
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki